Understanding the distribution dynamics within the US cystic fibrosis market is essential for stakeholders looking to navigate this complex landscape. With a current market size estimated at USD 1,436.4 million for 2024 and an anticipated growth trajectory leading to USD 5,484.15 million by 2035, the regional variations in prevalence and treatment access reflect critical underlying factors. The...